Sign In

Josh Aber

Director, Biopharma Business Development at Natera

Josh Aber is the Director of Biopharma Business Development at Natera, a role he has held for several years. He has over 20 years of experience in sales, marketing, and business development, demonstrating a progressive career in the biopharma and healthcare sectors. Aber's educational background includes studies at Saint Mary's College of California, which has contributed to his expertise in the industry.1

Highlights

Jun 13 · linkedin

Please join us for a recap of all the Natera data at ASCO.

May 14 · linkedin

Natera has some exciting news to share! We will be presenting 12 posters and an oral presentation on breast cancer at #ASCO2024.

Explore our posters featuring data on the use of Signatera for a range of cancers including Breast cancer, CRC, GI/GEC, Lung cancer, Melanoma, Bladder cancer, Head and Neck cancer, Testicular cancer, and hereditary cancer testing.

If you are attending #ASCO24, let's plan to meet and discuss how Signatera can support your ongoing and upcoming trials. Please let me know you will be attending and we can schedule a time to meet.

Related Questions

What is Josh Aber's background in biopharma business development?
How did Josh Aber transition from ITV Studios America to Natera?
What are Josh Aber's key achievements in his 20-year career?
What is Josh Aber's role at Goosehead Insurance Agency?
How does Josh Aber's experience at CoStar Group influence his current position?
J
Add to my network

Location

San Francisco Bay Area